GSK-3 inhibitors
Details for Australian Patent Application No. 2006278829 (hide)
International Classifications
Event Publications
6 March 2008 PCT application entered the National Phase
PCT publication WO2007/017145 Priority application(s): WO2007/017145
3 December 2009 Amendment Made
The nature of the amendment is: Amend the applicant name from Neuropharma, S.A. to Noscira, S.A.
29 March 2012 Application Accepted
Published as AU-B-2006278829
26 July 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006278838-Human inhibitory anti-factor VIII antibodies binding to the A2 domain
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser